Rykov, Yuri G. http://orcid.org/0000-0002-9966-7117
Patterson, Michael D.
Gangwar, Bikram A.
Jabar, Syaheed B.
Leonardo, Jacklyn
Ng, Kok Pin
Kandiah, Nagaendran
Funding for this research was provided by:
Neuroglee Therapeutics
Article History
Received: 25 July 2023
Accepted: 9 January 2024
First Online: 25 January 2024
Declarations
:
: This study has received approval (reference number 2021/2426) from the SingHealth Centralised Institutional Review Board (CIRB). Written informed consent was obtained from all participants before enrolling in this study, in accordance with the guidelines outlined by the SingHealth CIRB. The informed consent process was designed to provide participants with a clear understanding of the study’s purpose, procedures, risks, and benefits, as well as their right to withdraw at any time.
: Not applicable.
: Y.G.R, B.A.G., M.D.P, S.B.J, and J.L. were or are employed by Neuroglee Therapeutics. K.P.N received no direct payment from the study sponsor for his contributions. N.K received support from Neuroglee Therapeutics as a paid consultant. Neuroglee Therapeutics provided financial support and was involved in the protocol design, data analysis and the decision to submit this manuscript.